Ardelyx
@ardelyx
Followers
1,694
Following
232
Media
387
Statuses
531
Translating Scientific Breakthroughs into Promise for Patients. Community Guidelines:
Waltham, MA
Joined November 2016
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Leyen
• 318645 Tweets
Ursula
• 248840 Tweets
#BamBam
• 184875 Tweets
DAOUOFFROAD COL EP4
• 128738 Tweets
Kamari
• 73446 Tweets
Ali Koç
• 71870 Tweets
#BAMESIS
• 70934 Tweets
岸田総理
• 47843 Tweets
Mehmet Büyükekşi
• 45561 Tweets
डिब्रूगढ़ एक्सप्रेस
• 41589 Tweets
Gill
• 39489 Tweets
国立公園
• 37000 Tweets
T20I
• 34828 Tweets
AMIA
• 34735 Tweets
Hardik
• 33612 Tweets
マンション爆発
• 33021 Tweets
高級リゾートホテル誘致
• 24736 Tweets
西川口の爆発
• 23690 Tweets
TFF Başkanı
• 20634 Tweets
#MaskShadesCap
• 19492 Tweets
Sanju
• 17944 Tweets
ODIs
• 17584 Tweets
Kimiko
• 15336 Tweets
What's your color
• 15204 Tweets
テレ東BIZ
• 13163 Tweets
Hulk Hogan
• 10857 Tweets
We are thrilled to announce that today we received
@US_FDA
approval for another first-in-class therapy
#FDAApproval
#ArdelyxProud
8
49
157
Press Release: Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States $ARDX
1
16
73
Press Release: Tenapanor for Hyperphosphatemia Approved in Japan $ARDX
3
15
71
Press Release: XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia $ARDX
3
15
69
Press Release: FDA Grants Appeal for Ardelyx’s XPHOZAH® (tenapanor)
Read more here:
6
13
51
Press Release: Ardelyx Announces FDA Advisory Committee Votes that the Benefits of XPHOZAH® (tenapanor) Outweigh its Risks for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis
3
11
47
Press Release: Ardelyx Shares Positive Data and hosts IBS-C Product Theater at ACG 2023 $ARDX
1
9
47
Today we reported financial results for the first quarter of 2024 and provided a business update. Read the press release here: $ARDX
2
7
44
Save the date! We will present first quarter 2024 financial results and provide a business update on Thursday, May 2 at 4:30 PM ET via live webcast and conference call. Learn more: $ARDX
2
14
44
We have much to be thankful for this year. So, from our family to yours, we wish you a very
#HappyThanksgiving
#ArdelyxProud
3
0
39
Press Release: Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings.
1
11
37
Press Release: Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility $ARDX
0
14
39
The Ardelyx team had a great time connecting with esteemed
#nephrologists
at the
@USRenalCare
Medical Director’s Meeting in Las Vegas, NV
#ArdelyxProud
2
4
38
Senators Ben Ray Luján and Marsha Blackburn have introduced the bipartisan Kidney PATIENT Act, which would delay for two years the inclusion of oral-only phosphate binding medication into the ESRD Prospective Payment System. Learn more here:
0
6
38
'Tis the Season! The Ardelyx team rocked their most festive holiday sweaters during our new hire training this week!
#ardelyxproud
7
6
37
Press Release: Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at the 2023 Digestive Disease Week Conference.
1
10
37
Press Release: Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital $ARDX
2
8
36
Press Release: Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 IBSRELA® Net Sales Revenue Guidance. $ARDX
0
7
37
As we continue to support
#NationalKidneyMonth
, our Chief Financial & Operations Officer, Justin Renz, is sharing his personal story to bring awareness to
#kidneyhealth
and encourage people to take steps to keep their own kidneys safe and healthy.
2
4
36
Press Release: Ardelyx Resubmits New Drug Application to U.S. Food and Drug Administration for XPHOZAH® (tenapanor)
1
9
36
Another Step in XPHOZAH’s Path to Patients. A Message from the President and CEO, Mike Raab
3
9
34
Save the date! We will present fourth quarter and full year 2023 financial results and provide a business update on Thursday, February 22 at 4:30 PM ET via live webcast and conference call. Learn more:
1
4
34
Happy Holidays from our family to yours! As we reflect on 2022 and look forward to the new year, we’re incredibly grateful to our employees, patients, and partners.
2
5
31
0
8
32
Today we announced additional data to be presented at
@DDWMeeting
, to be held May 18-21, in Washington, D.C. Learn more:
#DDW2024
1
1
32
Today we announced additional data to be presented at the
@NKF
Spring Clinical Meetings, to be held May 14-18, in Long Beach, California. Learn more:
#NKFClinicals
1
9
32
We are proud to sponsor the latest
@GastroGirl
episode with
@mackenziepa24
@dbrennerGIMD
@BethRosenRD
@DrRiehl
and
@GIPsychUSA
sharing their expertise on
#IBSC
symptom relief and the provider’s POV on what better means to the patient. Check it out here:
4
8
30
Team Ardelyx has arrived in Washington D.C. for
@DDWMeeting
! Over the next couple of days, make sure to connect with our incredible team at booth
#1601
.
#DDW2024
0
1
31
A big thank you to our latest
#GI
KOL spotlight series speaker, Dr. Mark Pimentel, who joined us live in our Fremont office to discuss the gut microbiome and its role in
#IBSC
.
#ArdelyxProud
0
5
30
0
3
30
Happy New Year from Ardelyx! We’re grateful for the opportunity to continue advancing our mission to deliver innovative medicines that matter for patients with significant unmet needs – in 2023 and beyond.
3
2
29
Ardelyx wishes a Happy Veterans Day to all who have served our country. Thank you for your bravery, strength and dedication
#VeteransDay
0
3
30
Ardelyx is proud to be recognized as a 2022
#Fast500
winner by
@DeloitteTMT
a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America.
0
5
26
Today, in recognition of
#NationalEmployeeAppreciationDay
, we celebrate the incredible members of the Ardelyx team. Thank you for your commitment today and every day!
#Ardelyxproud
#EmployeeAppreciation
0
2
29
This
#NationalKidneyMonth
, hear from Ardelyx’s own VP, Nephrology David Spiegel, MD on one thing he wishes people knew about chronic kidney disease and the inspiring and resilient individuals who are living with this diagnosis.
0
3
28
Press Release: Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance. Read more here: $ARDX
0
4
28
Press Release: Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023 $ARDX
0
3
26
Last week, we lit the Prudential Center in Boston, as well as our offices, periwinkle in honor of
@WorldIBSDay
. We’re proud to offer our support to the
#IBS
community and help raise awareness through lighting up the sky!
#WorldIBSDay
#ArdelyxProud
0
3
27
Ardelyx is proud to partner with
@KidneyPatients
to sponsor the first ever
#NationalPhosphorusAwarenesDay
! We believe it’s imperative for patients to feel empowered and make informed decisions about managing their phosphorus levels.
0
3
27
At
@ASNKidney
#Kidneywk
? Connect with the team at booth
#2105
and join us tomorrow to hear Dr. David Spiegel and Dr. Arnold Silva speak at our Exhibitor Spotlight titled: A New Paradigm: Rethinking Hyperphosphatemia Management
0
5
25
Today is
@WorldIBSDay
, and Team Ardelyx is proud to show up for and amplify the voices of
#IBS
community. This week, our team had the opportunity to hear from patients and advocates, to better understand their journey and the impact of the disease.
#ArdelyxProud
0
6
26
What a great discussion at our fireside chat with CEO Mike Raab and our VP of Sales on the future of Ardelyx and how we can best support
#IBSC
patients and healthcare providers
#ArdelyxProud
0
4
24
We are excited to welcome
@JohannahRuddy
M.Ed to Team Ardelyx. Johannah will support the
#IBSC
community and bring the voice of patients to our company and culture
#ArdelyxProud
0
1
25
Attending
@ASNKidney
#KidneyWk
11/2-11/5? Connect with the team at booth
#2105
and join us on 11/3 to hear Dr. David Spiegel and Dr. Arnold Silva speak at our Exhibitor Spotlight titled: A New Paradigm: Rethinking Hyperphosphatemia Management
0
6
25
We’re excited to announce the appointment of Mike Kelliher to the position of Executive Vice President, Corporate Development and Strategy. Welcome to Team Ardelyx! Learn more:
1
1
25
#TBT
Our team attended
@NASPGHAN
2023 where we presented two posters. A big thank you to the health care professionals participating in our current pediatric trials!
#ArdelyxProud
0
2
25
Press Release: Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023.
0
5
23
Where will Team Ardelyx be this month? We have a whole new round up of
#GI
and
#kidneydisease
conferences we'll be attending!
0
3
24
#TBT
to an incredible
#ASN
#KidneyWk
. Thanks to everyone who stopped by our booth, checked out our posters, attended our Exhibitor Spotlight and connected with our team. See you next year!
#ArdelyxProud
0
2
23
From all of us at Ardelyx, best wishes to all around the world celebrating the Lunar New Year! We wish you peace and good fortune.
#yearoftherabbit
0
0
22
Ardelyx is excited to attend and participate in
#DDW2023
. Come hear Dr.
@dbrennerGIMD
at our product theater TODAY, May 8, from 9:30-10:15 am CT, talk about a different mechanism of action to treat adults with
#IBSC
0
4
24
Happy
#InternationalWomensDay
from all of us at Ardelyx! Today and every day, we embrace equity, diversity, and inclusion and are proud of all the achievements made towards equality.
#EmbraceEquity
#IWD2023
#ArdelyxProud
0
1
24
Join us for a virtual broadcast A New Paradigm: Rethinking Hyperphosphatemia Management featuring Dr. Glenn M. Chertow and Dr. Arnold Silva on Thursday 12/14 9pm ET/6pm PT. To register, please visit
0
2
24
Hearing from patients is critical for us to ensure that patients remain the center of everything we do. Today, we had the good fortune of hosting Jeffrey Roberts, Founder of the
@IBSpatient
Support Group and a patient himself. We thank him for all his great work in
#IBSC
advocacy
1
1
22
At Ardelyx, we come to work each day eager to make a difference for patients and the communities that serve them by developing first-in-class treatments that address significant unmet needs. Learn more about working at Ardelyx:
1
1
23
Today is
#WorldIBSDay
! Worldwide, an estimated 10-15% of the population is affected with irritable bowel syndrome
#IBS
. Today, we join patients, family members, and healthcare professionals to increase public awareness about IBS.
0
9
23
We’re excited to announce the launch of
@ArdelyxMedical
! We invite HCPs to follow for the latest in scientific discussion and insights from our team.
Explore medical insights with
@Ardelyx
! Our Medical Affairs team collaborates with healthcare practitioners to provide the latest data for informed practice. We invite HCPs to connect with us to delve into science, innovation, and patient care.
0
1
3
0
3
23
Ardelyx is excited to attend and participate in
#DDW2023
. Come hear Dr.
@dbrennerGIMD
talk about a different mechanism of action to treat adults with
#IBSC
at our product theater on May 8, 9:30-10:15 am CT.
0
3
23
As we continue to support and raise awareness during
#NationalKidneyMonth
, Ardelyx was proud to celebrate all the great advocates at the
@nkf
’s 2023 Congressional Awards Reception last week. Congratulations to
@cindyhydesmith
@RepGwenMoore
and Roberta “Bobbie” Reed
0
2
23
Please join us to hear leading nephrologists present A New Paradigm: Rethinking Hyperphosphatemia Management, on Jan 18 at 6pm ET, Jan 24 at 8pm ET or Jan 29 at 9pm ET. Click here to sign up:
0
5
23
The Ardelyx team had the great pleasure of connecting with Dr. Mariam Naveed
@MN_GIMD
and the
#GICommunity
at the AdventHealth Evolution of Women's Health in Gastroenterology Conference in November
#IBS
C
#Gastroenterology
#WomeninGI
#GITwitter
0
4
22
Another great
#ACG2023
! Thanks to everyone from the global
#GI
community who stopped by our booth, checked out our posters and oral presentation and connected with our team. See you next year!
#ArdelyxProud
0
3
22
We had an amazing time last weekend at the
@nkf
Northern California Kidney Walk in San Jose. Thanks to all who walked and rallied support for the kidney community!
#KidneyWalk
#ArdelyxProud
0
1
22
Ardelyx is thrilled to be exhibiting at the
@StanfordCME
2023 Updates in Gastroenterology & Hepatology, April 13-15th in Redwood City, CA
0
3
22
The Ardelyx National Meeting was a huge success! It was a productive week with great conversations and inspiring ideas. Congrats to our exceptional team and our award winners.
#ArdelyxProud
1
2
22
Ardelyx is proud to sponsor the
@TuesdayNightIBS
World IBS Day webinar TONIGHT featuring
@dbrennerGIMD
,
@DrRiehl
,
@KateScarlata_RD
talking about IBS-C. Register now:
0
6
21
Ardelyx is proud to sponsor the
@TuesdayNightIBS
World IBS Day webinar on April 19 featuring
@dbrennerGIMD
,
@DrRiehl
,
@KateScarlata_RD
talking about IBS-C. Register now:
0
6
20
Team Ardelyx came together to participate in the
@NKF
’s Drive for Dialysis program. We were honored to prepare care packages to help make patients’ dialysis experience a bit easier.
#ArdelyxProud
1
4
22
The Ardelyx team came together to participate in the
@nkf
's Drive for Dialysis program to pack care packages for local dialysis patients, furthering awareness surrounding kidney health, while supporting an important community cause.
#ardelyxproud
1
3
22
A big thanks to
@dbrennerGIMD
, Professor of Medicine
@NorthwesternMed
, and Amy Ladewski, Physician Assistant within the Digestive Health Center
@NorthwesternMed
, for joining us at our National Meeting to share their experiences treating patients with
#IBSC
.
#ArdelyxProud
0
3
21
Attending
@RPANephrology
’s Annual Meeting April 11 – 14 in Baltimore, Maryland? Make sure to stop by and connect with our team!
0
2
22
Attending
@ADHGastro
’s Enhancing GI & Liver Clinical Care Conference this weekend? Make sure to stop by Dr. Kavita Kongara’s presentation “Discover a Different Mechanism of Action to Treat Adults with IBS-C: A Case-Based Discussion” and connect with our team.
#GI
#IBS
0
4
22
Paul Pereira, our Head of Patient Advocacy, joined speakers at the 3rd Chief Patient Officer Summit in Boston to highlight ways to incorporate the patient voice in everything we do.
#ArdelyxProud
0
5
22
Press Release: Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)
0
2
22
We are honored to be an awardee of the Healthcare Technology Report’s Power 500 Healthcare Technology Companies of 2023 awarded to the most innovative and impactful organizations of the healthcare technology market.
#ardelyxproud
1
6
19
Press Release: Ardelyx Presents Positive Data at DDW 2023 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
0
2
21
Attending
@DDWMeeting
? Stop by Dr. Brooks Cash’s presentation: “Discover a Different Mechanism of Action to Treat Adults With IBS-C: A Case-Based Discussion.” Learn more:
#DDW2024
0
3
20
Today we announced that in an effort to preserve patient access to XPHOZAH, we have chosen not to apply for inclusion in the CMS End-Stage Renal Disease Prospective Payment System TDAPA. Learn more:
25
6
21
We had a great training this week surrounded by awesome vibes and inspiring energy! The team is ready to take its game to the next level working together to reach our goals and strive for success!
#ArdelyxProud
1
2
21
This
#MothersDay
, we’re honored to recognize all the
#workingmoms
at Ardelyx! Please join us in celebrating all the moms making a difference for patients and for their families!
#ArdelyxProud
0
0
21
Press Release: Ardelyx to Participate in Upcoming Investor Conferences
0
7
20
Giving back feels great! Our Medical Affairs team spent time sorting and portioning food for families at
@HarvestersORG
. Their food network feeds about 226k people in the Kansas City, MO area each month! Go team!
#ArdelyxProud
1
5
20
Press Release: Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at NASPGHAN 2023 $ARDX
0
3
20
A big Ardelyx welcome to all of our new hires! Want to be part of our team? Check out our open positions here:
#ardelyxproud
1
2
20
Press Release: Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update. Tune in here at 4:30 PM ET:
0
4
20
Happy Halloween from all of us at Ardelyx! 🎃👻 Wishing you all a spooky, fun, and safe holiday! 🤩
#HappyHalloween
#ArdelyxProud
0
2
21
We're celebrating Team Ardelyx today! Thank you to all our amazing employees who go above and beyond every single day! Your hard work and dedication make our success possible and we can't thank you enough!
#ThankYou
#TeamWork
#EmployeeAppreciation
#ArdelyxProud
0
1
21
Press Release: Ardelyx Collaboration Partner, Kyowa Kirin, Announces Submission of New Drug Application for Tenapanor for Hyperphosphatemia in Japan.
0
5
20
Press Release: Ardelyx to Present Data Updates at
@ASNKidney
Kidney Week 2023 November 1-5 in Philadelphia, PA
$ARDX
#KidneyWk
2
3
19
Our Medical Affairs team recently volunteered at the
@RMHDallas
, which serves families who need a place to stay while their child receives needed medical care. The team cleaned up the playrooms, living rooms, and more!
#ArdelyxProud
0
3
20
We had a great time at the
@AmCollegeGastro
Functional GI Disorders School making great connections with the
#GI
community. A special thanks to Dr.
@GregSayuk
for leading an engaging discussion around different mechanisms of action to treat adults with
#IBSC
#ArdelyxProud
1
1
20